Integration of in vitro data and brain weight in allometric scaling to predict clearance in humans: some suggestions.
Mahmood
I
I
Division of Pharmaceutical Evaluation I, Food & Drug Administration, Rockville, Maryland 20852, USA. Mahmoodi@CDER.FDA.GOV
D001921:Brain / Q000378:metabolism*; D006801:Humans; D009929:Organ Size; D010599:Pharmacokinetics